OmRx Oncology
Phase 2Discover OmRx Oncology's groundbreaking oral checkpoint inhibitors, making life-saving cancer immunotherapy accessible and affordable worldwide.
Founded
2019
Focus
Small Molecules
About
Discover OmRx Oncology's groundbreaking oral checkpoint inhibitors, making life-saving cancer immunotherapy accessible and affordable worldwide.
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile